Our start-up ecosystem
Reducing the environmental footprint of pharmaceutical micro-pollutants discharged into waters
MEDIX is a growing start-up, which promotes the growth of certain organisms, capable of degrading a large panel of micro-pollutants of pharmaceutical origin, to reach an overall reduction greater than 85%!
This start-up is distinguished by its high performance, low energy consumption, innovative process as well as its modularity and ease of integration on a greenfield site or within an existing environment.
The objective of Medix is to reduce the environmental footprint of pharmaceutical micro-pollutants discharged into waters. This leaves the opportunity for any stakeholder in the chemical or medical industry to take their environmental responsibility in hand and differentiate themselves from their competitors.
By strengthening in the treatment of waters polluted by pharmaceuticals and only partially treated in urban wastewater treatment plants.
MEDIX offers a turnkey solution for the treatment of pharmaceutical micro-pollutants, suitable for all volumes and compositions of discharges. Medix® will ensure, for its customers, the treatment of micro pollutants, as well as macro-pollutants, of their effluents through an innovative technology, which is based on a biological degradation process.
From design to operation, this is the product and services that MEDIX delivers to its customers:
- Study and characterisation of needs;
- Implementation of turnkey installations;
- Starting up and optimising;
- Monitoring and exploitation.
Who is the proposed solution for?
Primarily for hospitals, but also for chemical and pharmaceutical industries, etc. in the private sector market.
The team currently consists of two people:
Olivier Henriet — Process Engineer
David Costantini — Business Development Manager and expert at John Cockerill Balteau.
The team also relies on the support and expertise of the environmental sector group at John Cockerill.